Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue

Recruiting Phase 2 Interventional Study
Neoplasms Blood Cancer Fatigue Diet Habit Survivorship Fasting, Intermittent
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Supportive Care
Participants needed
96 (estimated)
Sponsor
University of Maryland, Baltimore · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cancer-related fatigue affects at least 30-90% of patients with cancer, depending on the type of cancer and their treatment(s) (e.g., chemotherapy, radiation). It is not relieved by sleep or rest, and it sometimes can persist for years after a person's cancer was treated. The fatigue can be so bad that people cannot return to work, hobbies, family roles, or other daily activities, thereby greatly …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria (Participants must…): * Have a diagnosis of a hematologic neoplasm (e.g., leukemia, lymphoma, multiple myeloma); * Be at least 2 months post-treatment with chemotherapy, radiation, targeted therapy, chimeric antigen receptor (CAR)-T cell therapy, stem cell transplant, or another …
Contacts

Amber Kleckner

4107065961

amber.kleckner@umaryland.edu

CONTACT